insights_auto
Hvorfor er NXTCL faldet med 9,95%?
Dyk dybere nedchevron_right
NXTCL:STO
NextCell Pharma AB
0,25 SEK
arrow_downward
-9,95%(-0,028) 1D
9. nov., 17.29.32 GMT+1 · SEK
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for NXTCL...
Åbn
0,26 SEK
Høj
0,27 SEK
Lav
0,24 SEK
Markedsværdi
32,21 mio.
Gns. vol.
1,01 mio.
Volumen
680,17 t
Højeste i 52 uger
1,78 SEK
Laveste i 52 uger
0,20 SEK
Indtægt pr. aktie
-0,45 SEK
Aktier i omløb
111,39 mio.
Antal ansatte
21
Åbn
0,26 SEK
Høj
0,27 SEK
Lav
0,24 SEK
Markedsværdi
32,21 mio.
Gns. vol.
1,01 mio.
Volumen
680,17 t
Højeste i 52 uger
1,78 SEK
Laveste i 52 uger
0,20 SEK
Indtægt pr. aktie
-0,45 SEK
Aktier i omløb
111,39 mio.
Antal ansatte
21
Nyhedshistorier
Fra webkilder og nyhedspartnere
Bloomberg.com
·
for 3 timer siden
Watch S&P 500 Erases Midterm Losses, Bitcoin Bounce
Investing.com
·
for 3 timer siden
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.15%
ChartMill
·
for 6 timer siden
Most-Active S&P 500 Stocks in Today's Session
StoneX
·
for 9 timer siden
S&P 500 Forecast: SPX rises despite Nvidia’s decline
Profil
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
Om NextCell Pharma AB
Administrerende direktørMathias Svahn
Ansatte21
Grundlagt19. mar. 2014
Hovedsæde-
SektorHealth Care
Branche-
Websitenextcellpharma.com